CLARITIN-D

GPTKB entity

Statements (60)
Predicate Object
gptkbp:instance_of gptkb:pharmaceuticals
gptkbp:approves gptkb:2000
gptkb:FDA
gptkbp:available_in various strengths
gptkbp:available_on gptkb:tablet
gptkbp:average_temperature room temperature
gptkbp:body_shape oval
gptkbp:class gptkb:Antihero
decongestant
gptkbp:clinical_trial yes
gptkbp:color gptkb:blue
gptkbp:contains gptkb:loratadine
gptkb:pseudoephedrine
gptkbp:contraindication hypertension
MAO inhibitors
severe coronary artery disease
gptkbp:dosage_form extended-release tablet
gptkbp:formulation oral
https://www.w3.org/2000/01/rdf-schema#label CLARITIN-D
gptkbp:imprints gptkb:CLARITIN-D
gptkbp:ingredients gptkb:loratadine
gptkb:pseudoephedrine
gptkbp:interacts_with gptkb:beer
other antihistamines
certain antidepressants
gptkbp:manufacturer gptkb:Bristol-Myers_Squibb
gptkbp:marketed_as gptkb:Australia
gptkb:Canada
gptkb:United_States
gptkbp:packaging blister pack
gptkbp:patient_population do not exceed recommended dose
consult doctor if symptoms persist
read the label
take as directed
gptkbp:previous_name yes
loratadine and pseudoephedrine
gptkbp:requires false
gptkbp:route_of_administration oral
gptkbp:safety consult healthcare provider
gptkbp:side_effect fatigue
headache
nausea
stomach upset
drowsiness
insomnia
dry mouth
nervousness
gptkbp:strength 120 mg pseudoephedrine
5 mg loratadine
gptkbp:suitable_for pregnant women
children under 12
nursing mothers
gptkbp:symptoms confusion
seizures
none reported
rapid heartbeat
severe dizziness
gptkbp:used_for allergy relief
gptkbp:bfsParent gptkb:Claritin-D
gptkbp:bfsLayer 6